Source link : https://www.newshealth.biz/health-news/fda-approves-new-option-for-rosacea/
The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical announced on Monday. Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials — MVOR-1 and MVOR-2 — involving 653 adults with papulopustular rosacea. Participants were randomized to […]
Author : News Health
Publish date : 2024-11-04 21:02:52
Copyright for syndicated content belongs to the linked Source.
